Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 2,115 $ 5,343
Accounts receivable, net 4,849 4,339
Non-trade receivable 6,452 7,119
Related party receivable 181 181
Inventory 8,620 10,621
Prepaid expenses and other current assets 4,718 4,562
Total current assets 26,935 32,165
Property and equipment, net 188 227
Contract fulfillment assets 8,014 6,399
Other assets 821 948
Total assets 35,958 39,739
Liabilities and stockholders’ equity (deficit)    
Accounts payable 17,294 22,848
Accrued liabilities 15,118 20,892
Promissory note, net, current portion 2,265
Total current liabilities 34,677 43,740
Promissory note, net 566
Income tax payable 1,794 1,699
Total liabilities 37,037 45,439
Commitments and contingencies (Note 8)
Stockholders’ equity (deficit)    
Common stock, $0.001 par value per share; 100,000,000 shares authorized; and 6,333,657 and 4,983,868 shares issued and outstanding at March 31, 2025, and December 31, 2024, respectively 6 5
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized, and no shares issued and outstanding at March 31, 2025, and December 31, 2024, respectively
Additional paid-in capital 282,065 277,903
Accumulated deficit (283,150) (283,608)
Total stockholders’ equity (deficit) (1,079) (5,700)
Total liabilities and stockholders’ equity (deficit) $ 35,958 $ 39,739